Best Life Sciences Companies in Louisiana, United States
The 53 best Life Sciences companies in Louisiana, United States in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: Emisphere.
Our analysis of 164 Life Sciences companies
$34.7b in tracked funding; 83% of the stack-profiled cohort runs cloud-native; funding activity peaked in 2025.
Ranked: Best Life Sciences companies in Louisiana
| # | Company | Disclosed funding | Last round | Employees | Founder | Stage | Patents & IP focus | Recent signals |
|---|---|---|---|---|---|---|---|---|
| 1 | Emisphere Global healthcare company driving change to defeat diabetes and other serious diseases | $50M | 158 mo ago | 8 | — | Acquired | — | — |
| 2 | Molecular Biometrics Innovating healthcare through metabolomics and gastronomy, sharing culinary passion | $13M | 212 mo ago | — | James Posillico President & CEO | Series B | — | — |
| 3 | Corbus Pharma Develops therapeutics solutions for the chronic, inflammatory and fibrotic diseases | $10M | 101 mo ago | 19 | — | Public | — | — |
| 4 | Wavegate Corporation Developer of smart devices for spinal cord stimulation | $10M | 16 mo ago | 5 | Erich Wolf President and CEO | Series A | 54 patents Patents concentrated in health & consumer products | — |
| 5 | Autoimmune Technologies Biomedical company developing diagnostic and therapeutic technologies for unmet medical needs | $9M | 95 mo ago | 7 | Michael Charbonnet CEO | Funding Raised | 80 patents Patents concentrated in chemistry & materials | — |
| 6 | LifeVantage Provider of nutritional products for multiple health ailments | $8M | 197 mo ago | 248 | — | Public | 25 patents Patents concentrated in health & consumer products | — |
| 7 | BioAesthetics Developer of a tissue-engineered nipple-areolar complex | $7M | 47 mo ago | 13 | Nicholas Pashos Founder & CEO | Series A | 25 patents Patents concentrated in health & consumer products | — |
| 8 | IOM Services Neuro-physiological monitoring device and services for operation theaters | $6M | — | 62 | — | Deadpooled | — | — |
| 9 | South Rampart Pharma Developer of drugs for treating acute, chronic and neuropathic pain | $4M | 50 mo ago | 3 | Nicolas Bazan Co-Founder | Funding Raised | — | 1 award |
| 10 | Obatala Sciences Provider of research enabling products and services to research centers | $4M | 45 mo ago | 10 10 → 10 (+0%) | Xiying Wu Co-Founder | Series A | — | — |
| 11 | AxoSim Engineering human brain and nerve models for neurological insights | $3M | 20 mo ago | 27 | — | Series A | 24 patents Patents concentrated in computing, sensing & instrumentation | — |
| 12 | Bioceptive Developer of medical devices for gynecological procedures | $3M | 125 mo ago | 2 | Benjamin Cappiello Founder & Board Member | Seed | 34 patents Patents concentrated in health & consumer products | — |
| 13 | Ashlar Medical Products for the treatment and diagnosis of urinary conditions | $3M | 169 mo ago | 10 | David Waskom CEO | Seed | — | — |
| 14 | NanoPin Technologies Provider of infectious disease diagnostics solution with a nanotechnology-enabled platform | $3M | 58 mo ago | — | Thomas Tomble CEO | Funding Raised | — | — |
| 15 | NuPotential Drug discovery platform for the treatment of cancer | $2M | 153 mo ago | 12 | Kenneth Eilertsen Founder & CEO | Seed | 44 patents Patents concentrated in chemistry & materials | — |
| 16 | OncBioMune Developing novel cancer immunotherapy products with a proprietary vaccine technology | $2M | 85 mo ago | 16 | Jonathan Head CEO | Public | 27 patents Patents concentrated in health & consumer products | — |
| 17 | Zenopharm Early-stage biotech developing cancer therapeutics | $2M | 93 mo ago | — | Guangdi Wang Co-Founder & CEO | Funding Raised | — | — |
| 18 | Instapath Innovative digital pathology solutions for faster, lossless tissue analysis | $2M | 64 mo ago | 10 | Mei Wang CEO | Seed | 10 patents Patents concentrated in transport & manufacturing processes | — |
| 19 | InnoGenomics Innovative genetic testing solutions to solve crimes and save lives | $2M | 102 mo ago | 12 | Sudhir Sinha CEO & President | Funding Raised | 3 patents Patents concentrated in chemistry & materials | — |
| 20 | Henley Ion Developer of miniaturized electrostatic precipitator technology for respiratory and air purification systems | $2M | 35 mo ago | 7 | John Hinds Co-Founder | Funding Raised | — | — |
| 21 | LaCell Human-derived biomaterials and organ-on-a-chip models for preclinical drug development | $2M | 120 mo ago | 6 | Xiying Gimble Co-Founder & Director | Funding Raised | — | — |
| 22 | Levisonics Developer of hemostatic assays | $974K | 25 mo ago | 4 | Damir Khismatullin Co-Founder & President | Funding Raised | 2 patents Acoustic levitation containment cartridges and apparatuses for manipulating particles | — |
| 23 | TumorEnd Early stage biotech developing complex carbohydrate vascular disruptors as oncology therapeutics | $299K | 154 mo ago | — | Roger Laine CEO | Deadpooled | 7 patents Patents concentrated in chemistry & materials | — |
| 24 | Informuta Provider of predictive diagnostics for drug-resistant infections | $275K | 22 mo ago | — | Kalen Hall Co-Founder & CEO | Funding Raised | — | — |
| 25 | Keliomics Provider of ex vivo cancer models for research | $250K | 23 mo ago | 4 | Jason Bourgeois Co-Founder | Seed | — | — |
| 26 | RE CoolingTech Provider of cooling technology to enhance athletic performance | $225K | 71 mo ago | — | Phillip Immesoete Co-Founder | Seed | — | — |
| 27 | Segue Therapeutics Proprietary high content imaging platform to discover and commercialize repurposed drugs for the treatment of… | $170K | 119 mo ago | 8 | Jim Cardelli Founder & CEO | Seed | — | — |
Top 12 Life Sciences companies in Louisiana
#1
Series A · Lake Charles, Louisiana · founded 2019 · 5 employees$10Mraised▾
Developer of smart devices for spinal cord stimulation. Its main product is the Ellipse platform which uses proprietary technologyStimuLux and Active Loop designed to adjust stimulation.
- Mar 2025Series A$2.8M
- Dec 2024Series A$26M
- Mar 2023Seed$10M
#2
Series A · New Orleans, Louisiana · founded 2014 · 27 employees$3.1Mraised▾
Engineering human brain and nerve models for neurological insights, this company integrates tissue engineering, neural interfacing, and Artificial Intelligence to create reproducible brain organoids. These models offer reliable central nervous system safety assessments and predict human neurological responses. They provide engineered brain and peripheral nerve models for functional human insights, serving applications in safety, oncology, and efficacy testing. The company offers both technology and services related to its CNS-3D and PNS-3D models. Resources include a library, application notes, scientific posters, webinars, publications, protocols, and FAQs. This is a B2B tech company focused on advancing neurological research and drug development through innovative, engineered human brain models.
- Nov 2024Series A$3.7M
- Sep 2020Grant (prize money)$227.9K
- Jun 2020Seed$2M
- Aug 2019Grant (prize money)$647K
#3
Funding Raised · New Orleans, Louisiana · founded 2023$275Kraised▾
Provider of predictive diagnostics for drug-resistant infections. It uses machine learning to analyze bacterial DNA to accurately guide effective treatment for difficult infections and predict if infections will become drug-resistant.
- Sep 2024Grant (prize money)$275K
#4
Seed · New Orleans, Louisiana · founded 2021 · 4 employees$250Kraised▾
Provider of ex vivo cancer models for research. It offers 5D microphysiological systems for solid tumors for analyzing tumor microenvironments, the composition of the extracellular matrix, and the presence or absence of immune cells.
- Aug 2024Grant (prize money)$398.9K
- Oct 2022Seed$250K
#5
Funding Raised · New Orleans, Louisiana · founded 2016 · 4 employees$974.5Kraised▾
Levisonics has developed a kit for bleeding/thrombosis risk testing. The diagnostic platform uses acoustic levitation technology for quantitative viscoelastic and optical measurements through a non-contact assessment of the blood sample. It is used in pediatrics, neonatal care, and home care settings. Some of the partners are Fraunhofer, Accelerate South, and Boston University.
- Jun 2024Grant (prize money)$299.3K
- Sep 2021Grant (prize money)$225.2K
- 2019Grant (prize money)$225K
- Feb 2019Grant (prize money)$225K
#6
Series A · New Orleans, Louisiana · founded 2015 · 13 employees$7.4Mraised▾
Developer of a tissue-engineered nipple-areolar complex. The company is commercializing its inaugural product a tissue-engineered nipple-areolar complex graft (NACgraft) which is used after a mastectomy, the surgeon would engraft the NAC graft onto the patient’s reconstructed breast. The patient’s body would then use this NAC graft as a building frame to regenerate its own NAC.
- Aug 2022Grant (prize money)$258.7K
- May 2022Grant (prize money)$3K
- Aug 2021Grant (prize money)—
- Jan 2021Grant (prize money)$2M
#7
Funding Raised · New Orleans, Louisiana · founded 2021 · 7 employees$1.8Mraised▾
Developer of miniaturized electrostatic precipitator technology for respiratory and air purification systems. The technology provides enhanced protection against various contaminants, including biological and chemical agents. It offers solutions for both personal respiratory protection and for integration into HVAC systems in residential, commercial, and industrial settings. The technology is based on research published in peer-reviewed journals. The company also provides industrial sales and support. A financial conflict of interest policy ensures ethical research practices.
- Aug 2023Grant (prize money)$1.8M
#8
Series A · New Orleans, Louisiana · founded 2017 · 10 employees$3.5Mraised▾
Provider of research enabling products and services to research centers. The platform offers multiple services such as adipose tissue-derived stromal stem cells, human adult primary cell, 3D discovery tools such as ObaGel and ObaCell among others. The platform also offers medial and culture reagents such as OsteoQual.
- Oct 2022Series A$3M
- Sep 2022Grant (prize money)$450.7K
- Oct 2020Seed$535K
#9
Acquired · Roseland, Louisiana · founded 1986 · 8 employees$50.2Mraised▾
Global healthcare company driving change to defeat diabetes and other serious diseases. It pioneers scientific breakthroughs, expands access to medicines, and works to prevent and ultimately cure disease. The company focuses on solutions to create long-term health, pushing the boundaries of science and making healthcare more accessible. It is dedicated to treating, preventing, and even curing serious chronic diseases such as obesity, rare blood, and endocrine disorders. The company operates in the pharmaceutical manufacturing industry, offering a range of medicines for approved indications. It emphasizes innovation and inspiring stories, championing long-term health through its unordinary mindset.
- May 2013Post IPO$35.2M
- Sep 2005Conventional Debt$15M
#10
Funding Raised · New Orleans, Louisiana · founded 2016 · 3 employees$4.2Mraised▾
South Rampart Pharma is a developer of drugs for treating acute, chronic, and neuropathic pain. It improves the lives of people suffering from acute, chronic, and neuropathic pain by developing a new class of non-opioid pain medicines. It uses drug metabolism, molecular modeling, and medicinal chemistry for the development of drugs. It reduces both pain & fever with no liver toxicity.
- May 2022Grant (prize money)—
- Sep 2020Grant (prize money)$399.5K
- Sep 2020Grant (prize money)$1.9M
- Sep 2020Grant (prize money)$1.9M
#11
Public · Norwood, Louisiana · founded 2009 · 19 employees$10.4Mraised▾
Corbus Pharma is a clinical-stage drug development company targeting rare, chronic, inflammatory, and fibrotic diseases. The company flagship product 'Resunab' is a novel synthetic oral endocannabinoid-mimetic drug that acts to resolve inflammation through an endogenous pathway. It triggers the production of specialized pro-resolving lipid mediators that activate an endogenous cascade responsible for the resolution of inflammation and fibrosis. This is currently in phase 2 trials testing for Cystic Fibrosis, Systemic Sclerosis, Dermatomyositis and Systemic Lupus Erythematosus.
- Jan 2018Grant (prize money)$25M
- Mar 2017Post IPO$27.2M
- Mar 2014Series A$10.3M
- Jan 2014Seed$90K
#12
Funding Raised · New Orleans, Louisiana · founded 1995 · 7 employees$8.6Mraised▾
Biomedical company developing diagnostic and therapeutic technologies for unmet medical needs. It focuses on discovering and developing groundbreaking products in areas like unique human monoclonal antibodies, patented stem cell antibody delivery platforms, and anti-viral drugs. The company researches and develops solutions for a range of conditions, including viral infections like Influenza, Dengue Fever, Hepatitis C, HIV/AIDS, and Ebola Fever, as well as rheumatic disorders such as Fibromyalgia Syndrome, Systemic Lupus Erythematosus, and Juvenile Rheumatoid Arthritis. It offers laboratory tests for conditions like Fibromyalgia, Lassa Fever, and Ebola Fever. The company operates in the biomedical and pharmaceutical industry, focusing on research and development to address unmet medical needs through innovative diagnostic and therapeutic technologies.
- Aug 2018Grant (prize money)$224.6K
- Sep 2017Grant (prize money)$239.9K
- Jun 2014Grant (prize money)$225K
- Jun 2009Grant (prize money)$3.9M
Funding & investor landscape
Notable founders
Market landscape — 10 sub-themes by coverage
Share of Life Sciences coverage by sub-theme.
Regulatory-risk over time rising
Funding & growth over time
funding rising · growth rising
What Louisiana researches in biotechnology
Louisiana State University Agricultural Center leads Louisiana's biotechnology research (37 papers, stance +0.52).
- Louisiana State University Agricultural Center13
- Louisiana State University12
- Louisiana State University Health Sciences Center New Orleans5
- University of Louisiana at Lafayette2
- Louisiana State University Health Sciences Center Shreveport2
Common questions
Riya reads income statements for fun. She covers the real money in a sector — revenue, growth, who actually earns — and never met a vague claim she didn't want a number for.